Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma and CLL co-occurrence and survival: role of KC history.
Zhao Y, Amorrortu RP, Stewart SC, Ghia KM, Williams VL, Sondak VK, Tsai KY, Pinilla-Ibarz J, Chavez JC, Rollison DE. Zhao Y, et al. Among authors: sondak vk. BMC Cancer. 2023 Nov 9;23(1):1084. doi: 10.1186/s12885-023-11573-z. BMC Cancer. 2023. PMID: 37946198 Free PMC article.
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.
Eljilany I, Noor A, Paravathaneni M, Yassine I, Lee SJ, Othus M, Moon J, Kirkwood JM, Sondak VK, Ribas A, Grossmann KF, Tarhini AA. Eljilany I, et al. Among authors: sondak vk. Cancers (Basel). 2023 Apr 29;15(9):2561. doi: 10.3390/cancers15092561. Cancers (Basel). 2023. PMID: 37174027 Free PMC article.
Melanoma in Pediatric and Young Adult Patients.
Sondak VK, Messina JL. Sondak VK, et al. Curr Oncol Rep. 2024 May 23. doi: 10.1007/s11912-024-01542-5. Online ahead of print. Curr Oncol Rep. 2024. PMID: 38780675 Review.
First-in-human stage III/IV melanoma​ clinical trial of immune priming agent IFx-Hu2.0.
Markowitz J, Shamblott M, Brohl AS, Sarnaik AA, Eroglu Z, Khushalani NI, Dukes CW, Chamizo A, Bastawrous M, Garcia ET, Delhawi A, Chen PL, De Aquino DB, Sondak VK, Tarhini AA, Kim Y, Lawman P, Pilon-Thomas S. Markowitz J, et al. Among authors: sondak vk. Mol Cancer Ther. 2024 Apr 24. doi: 10.1158/1535-7163.MCT-23-0652. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38657233
Systemic Therapy for Melanoma: ASCO Guideline Update Q and A.
Sondak VK, Atkins MB, Messersmith H, Provenzano A, Seth R, Agarwala SS. Sondak VK, et al. JCO Oncol Pract. 2024 Feb;20(2):173-177. doi: 10.1200/OP.23.00675. Epub 2023 Dec 1. JCO Oncol Pract. 2024. PMID: 38039436
Systemic Therapy for Melanoma: ASCO Guideline Update.
Seth R, Agarwala SS, Messersmith H, Alluri KC, Ascierto PA, Atkins MB, Bollin K, Chacon M, Davis N, Faries MB, Funchain P, Gold JS, Guild S, Gyorki DE, Kaur V, Khushalani NI, Kirkwood JM, McQuade JL, Meyers MO, Provenzano A, Robert C, Santinami M, Sehdev A, Sondak VK, Spurrier G, Swami U, Truong TG, Tsai KK, van Akkooi A, Weber J. Seth R, et al. Among authors: sondak vk. J Clin Oncol. 2023 Oct 20;41(30):4794-4820. doi: 10.1200/JCO.23.01136. Epub 2023 Aug 14. J Clin Oncol. 2023. PMID: 37579248
Acral melanoma: clinical advances and hope for the future.
Perez MC, Messina JL, Karapetyan L, Neves RI, Sondak VK. Perez MC, et al. Among authors: sondak vk. Clin Adv Hematol Oncol. 2023 Aug;21(8):400-409. Clin Adv Hematol Oncol. 2023. PMID: 37530614 Review.
431 results